MicroRNA-494 reduces DJ-1 expression and exacerbates neurodegeneration

Neurobiology of Aging

Volumn 35, Issue 3, 2014, Pages 705-714

  Xiong, Ran ^a   Wang, Zhiquan ^a   Zhao, Zongbo ^a   Li, Hui ^a   Chen, Wei ^a   Zhang, Bei ^a   Wang, Liling ^a   Wu, Li ^a   Li, Wen ^a   Ding, Jianqing ^a,b   Chen, Shengdi ^a,b  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

DJ 1; MiR 494; Oxidative stress; Parkinson's disease

Indexed keywords

DJ 1 PROTEIN; MICRORNA; MICRORNA 494; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

DJ-1; MIR-494; OXIDATIVE STRESS; PARKINSON'S DISEASE;

3' UNTRANSLATED REGIONS; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOPAMINE; GENE EXPRESSION; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MPTP POISONING; NEURONS; ONCOGENE PROTEINS; OXIDATIVE STRESS; PROTEIN BINDING;

EID: 84889568068     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.09.027     Document Type: Article

References (35)

1. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
2. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
3. Bonifati V., Oostra B.A., Heutink P. Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson's disease. J.Mol. Med. (Berl) 2004, 82:163-174.
4. Cho H.J., Liu G., Jin S.M., Parisiadou L., Xie C., Yu J., Sun L., Ma B., Ding J., Vancraenenbroeck R., Lobbestael E., Baekelandt V., Taymans J.M., He P., Troncoso J.C., Shen Y., Cai H. MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein. Hum. Mol. Genet. 2013, 22:608-620.
5. Choi J., Sullards M.C., Olzmann J.A., Rees H.D., Weintraub S.T., Bostwick D.E., Gearing M., Levey A.I., Chin L.S., Li L. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J.Biol. Chem. 2006, 281:10816-10824.
6. de Lau L.M., Breteler M.M. Epidemiology of Parkinson's disease. Lancet Neurol. 2006, 5:525-535.
7. Donnan G.A., Willis G.L., Kaczmarczyk S.J., Rowe P. Motor function in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse. J.Neurol. Sci. 1987, 77:185-191.
8. Doxakis E. Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J.Biol. Chem. 2010, 285:12726-12734.
9. Farrer M.J. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat. Rev. Genet. 2006, 7:306-318.
10. Furuya T., Hayakawa H., Yamada M., Yoshimi K., Hisahara S., Miura M., Mizuno Y., Mochizuki H. Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. J.Neurosci. 2004, 24:1865-1872.
11. Hutvagner G., Zamore P.D. AmicroRNA in a multiple-turnover RNAi enzyme complex. Science 2002, 297:2056-2060.
12. Jenner P. Oxidative stress as a cause of Parkinson's disease. Acta. Neurol. Scand. Suppl 1991, 136:6-15.
13. Jenner P., Dexter D.T., Sian J., Schapira A.H., Marsden C.D. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann. Neurol. 1992, 32(Suppl):S82-S87.
14. Jeyaseelan K., Lim K.Y., Armugam A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 2008, 39:959-966.
15. Keck-Wherley J., Grover D., Bhattacharyya S., Xu X., Holman D., Lombardini E.D., Verma R., Biswas R., Galdzicki Z. Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes. Dev. Neurosci. 2011, 33:451-467.
16. Kim W.K., Park M., Kim Y.K., Tae Y.K., Yang H.K., Lee J.M., Kim H. MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation. Clin. Cancer Res. 2011, 17:7584-7594.
17. Kruger J., Rehmsmeier M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res. 2006, 34:W451-W454.
18. Krutzfeldt J., Poy M.N., Stoffel M. Strategies to determine the biological function of microRNAs. Nat. Genet. 2006, 38(suppl):S14-S19.
19. Lan Y.F., Chen H.H., Lai P.F., Cheng C.F., Huang Y.T., Lee Y.C., Chen T.W., Lin H. MicroRNA-494 reduces ATF3 expression and promotes AKI. J.Am. Soc. Nephrol. 2012, 23:2012-2023.
20. Lang A.E., Lozano A.M. Parkinson's disease. First of two parts. N.Engl. J. Med. 1998, 339:1044-1053.
21. Lee S.J., Kim S.J., Kim I.K., Ko J., Jeong C.S., Kim G.H., Park C., Kang S.O., Suh P.G., Lee H.S., Cha S.S. Crystal structures of human DJ-1 and Escherichia coli Hsp31, which share an evolutionarily conserved domain. J.Biol. Chem. 2003, 278:44552-44559.
22. Majer A., Medina S.J., Niu Y., Abrenica B., Manguiat K.J., Frost K.L., Philipson C.S., Sorensen D.L., Booth S.A. Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice. PLoS Pathog. 2012, 8:e1003002.
23. Minones-Moyano E., Porta S., Escaramis G., Rabionet R., Iraola S., Kagerbauer B., Espinosa-Parrilla Y., Ferrer I., Estivill X., Marti E. MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum. Mol. Genet. 2011, 20:3067-3078.
24. Montag J., Hitt R., Opitz L., Schulz-Schaeffer W.J., Hunsmann G., Motzkus D. Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease. Mol. Neurodegener. 2009, 4:36.
25. Moore D.J., Zhang L., Dawson T.M., Dawson V.L. Amissense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo-oligomerization. J.Neurochem. 2003, 87:1558-1567.
26. Nural H., He P., Beach T., Sue L., Xia W., Shen Y. Dissembled DJ-1 high molecular weight complex in cortex mitochondria from Parkinson's disease patients. Mol. Neurodegener. 2009, 4:23.
27. Ohdaira H., Sekiguchi M., Miyata K., Yoshida K. MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells. Cell Prolif. 2012, 45:32-38.
28. Olanow C.W., Tatton W.G. Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 1999, 22:123-144.
29. Pan J., Li H., Ma J.F., Tan Y.Y., Xiao Q., Ding J.Q., Chen S.D. Curcumin inhibition of JNKs prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease through suppressing mitochondria dysfunction. Transl. Neurodegener. 2012, 1:16.
30. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2008, Academic Press, San Diego, CA.
31. Tanner C.M., Goldman S.M. Epidemiology of Parkinson's disease. Neurol. Clin. 1996, 14:317-335.
32. Tao X., Tong L. Crystal structure of human DJ-1, a protein associatedwith early onset Parkinson's disease. J.Biol. Chem. 2003, 278:31372-31379.
33. Wang Z., Liu J., Chen S., Wang Y., Cao L., Zhang Y., Kang W., Li H., Gui Y., Chen S., Ding J. DJ-1 modulates the expression of Cu/Zn-superoxide dismutase-1 through the Erk1/2-Elk1 pathway in neuroprotection. Ann. Neurol. 2011, 70:591-599.
34. Wang Z., Zhang Y., Zhang S., Guo Q., Tan Y., Wang X., Xiong R., Ding J., Chen S. DJ-1 can inhibit microtubule associated protein 1 B formed aggregates. Mol. Neurodegener. 2011, 6:38.
35. Warner T.T., Schapira A.H. Genetic and environmental factors in the cause of Parkinson's disease. Ann. Neurol. 2003, 53(suppl 3):S16-S25.